Johns Hopkins University and a consortium of seven other leading U.S. scientific and medical institutions today warned Congress that persistent flat funding of biomedical research could thwart advances in treatments for such diseases as cancer and Alzheimer’s disease, and erode U.S. dominance in science.>>> Discuss This Story
